You are on Trendlyne United States. Click here to go to India website or make United States as your default

Downs Christopher's Insider Trades & SAST Disclosures

Downs Christopher's most recent trade in Cns Pharmaceuticals Inc was a trade of 40,000 Restricted Stock Units done . Disclosure was reported to the exchange on April 8, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 40,000 241 - - Restricted Stock Units
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 40,000 201 - - Option to purchase common stock
Cns Pharmaceuticals Inc
Downs Christopher Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.30 per share. 01 Feb 2024 66,666 103,438 (0%) 0% 0.3 20,000 Common stock
Cns Pharmaceuticals Inc
Downs Christopher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 66,666 94,906 - - Series A Warrant to purchase common stock
Cns Pharmaceuticals Inc
Downs Christopher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 66,666 161,572 - - Series B Warrant to purchase common stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.27 per share. 22 Aug 2023 27,000 36,772 (0%) 0% 1.3 34,177 Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 521 9,772 (0%) 0% - Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 521 28,248 - - Restricted Stock Units
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.20 per share. 17 Apr 2023 3,100 9,251 (0%) 0% 3.2 9,920 Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2023 6,067 28,768 - - Restricted Stock Units
EBET Inc
Christopher Downs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2023 6,300 6,300 - - Common Stock
EBET Inc
Christopher Downs Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2023 6,300 75,000 - - Restricted Stock Units
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2022 250,000 681,000 - - Restricted Stock Units
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.31 per share. 11 Mar 2022 33,000 184,500 (1%) 0% 0.3 10,230 Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.94 per share. 06 Dec 2021 5,000 151,500 (0%) 0% 0.9 4,702 Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.15 per share. 19 Nov 2021 4,500 146,500 (0%) 0% 1.2 5,192 Common Stock
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2021 131,000 431,000 - - Option to purchase common stock (right to buy)
Cns Pharmaceuticals Inc
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.04 per share. 24 Aug 2020 142,000 142,000 (0%) 0% 2.0 289,680 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades